Document Mentions (3 shared documents)

EFTA00135712

2 mentions1 same-page

Page ?Same page

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ommission Executive Director Debbie Reed; 8:30 AM • POMED discussion on 'Mohammed bin Salman's Saudi Arabia' - 'Mohammed bin Salman's Saudi Arabia' Project on Middle East Democracy public virtual conference, with remarks from Democrats Sens. Chris Van Hollen and Tim Kaine and Reps. Gerald Connolly, Ro Khanna, Tom Mal

EFTA00148896

2 mentions1 same-page

Page ?Same page

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

EFTA01658495

2 mentions1 same-page

Page ?Same page

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ommission Executive Director Debbie Reed; 8:30 AM • POMED discussion on 'Mohammed bin Salman's Saudi Arabia' - `Mohammed bin Salman's Saudi Arabia' Project on Middle East Democracy public virtual conference, with remarks from Democrats Sens. Chris Van Hollen and Tim Kaine and Reps. Gerald Connolly, Ro Khanna, Tom Mal

Mutual Connections (893)

Entities connected to both Amgen and Project on Middle East

Jeffrey Epstein